Biogipuzkoa, the latest RaDAR buyer, has awarded the contract for the supply of materials to carry out the European RaDAR project, focused on the rapid detection of antibiotic resistance and the prevention of nosocomial infections caused by multidrug-resistant microorganisms.
The awarded company is:
Rapid and accurate detection to smart Antimicrobial Resistance (AMR) management, awarded to Qualud, a company which works on providing innovative technological platforms that helps improving people’s health.
The RaDAR team wishes to congratulate Qualud and invites you to stay tuned for new opportunities.
